GB00BRXB0C07
GB00BRXB0C07
Kiniksa Pharmaceuticals Interna
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 677.564.000 | 423.239.000 | 60.1% |
| Cost of Revenue | 307.218.000 | 60.910.000 | 404.4% |
| Gross Profit | 370.346.000 | 362.329.000 | 2.2% |
| 293.125.000 | 407.945.000 | 28.1% | |
| Operating Income | 77.221.000 | -45.616.000 | 269.3% |
| Pretax Income | 88.868.000 | -36.152.000 | 345.8% |
| Net Income Common Stockholders | 59.005.000 | -43.193.000 | 236.6% |
| -- | -- | -- | |
| -- | -- | -- |